Furthermore, VHL-mediated UBE3B downregulation in breast cancer cells could be restored by the proteasome inhibitor MG132 (Fig. 2K, L), indicating that VHL modulates UBE3B protein levels through the proteasomal system. This evidence concerns the gene UBE3B and breast cancer.